Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
PMCK's future prospects is looking real good with the medical consumables business plus the upcoming Kulim medical hub. At its current price & P/E 12 (industry peers ~P/E 30), it's defo a gem lol.
Rohas could benefit from the upcoming Sungai Rasau Phase 2 tender! Project value is significantly larger than the recently completed RM123mil phase 1 😉
"Meanwhile, Langat 2 Phase 2, estimated at RM3 billion to RM4 billion, has entered the procurement stage following pre-qualification for Packages 1 and 2, while Sungai Rasau Phase 2, worth an estimated RM2 billion to RM3 billion, could provide further water-related packages, " he said in a research note.
Companies like Elsoft & ECA are trading at >30 sen with over RM200m market cap while CLITE that is actually profitable is trading at this level with RM100mil cap. What a load of nonsense lol. This counter needs a re-rating badly.
My take: The ongoing legal dispute with IBSE certainly does not look good for a company that wanted to diversify from its O&G business into the EPCC segment. IBSE awarded a few TNB subcontracts to HAWK and within just a few months we're seeing news reports of alleged misappropriation. You think TNB would be comfortable doing businesses with these two entities going forward? Something to think about...
I can see many fake profiles/ insiders in the comments trying to con investors with the "rebound" and "oversold" narrative. Just click into some of these profiles and you'll notice that their last comment is 5-6 months ago and mostly about HAWK.
